SS
IRWD icon

Steve Schonfeld’s Ironwood Pharmaceuticals IRWD Stock Holding History

Steve Schonfeld’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$120K Sell
28,428
-29,949
-51% -$115K ﹤0.01% 2279
2026
Q1 		$205K Buy
+58,377
New +$239K ﹤0.01% 1734
2025
Q2 		– Sell
-307,337
Closed -$452K – 2271
2025
Q1 		$452K Buy
307,337
+52,297
+21% +$125K ﹤0.01% 1625
2024
Q4 		$1.13M Buy
255,040
+73,447
+40% +$298K 0.01% 1064
2024
Q3 		$748K Sell
181,593
-165,447
-48% -$889K 0.01% 1263
2024
Q2 		$2.26M Sell
347,040
-965,204
-74% -$6.83M 0.01% 858
2024
Q1 		$11.4M Buy
1,312,244
+1,239,268
+1,698% +$15M 0.08% 328
2023
Q4 		$835K Buy
72,976
+40,576
+125% +$401K 0.01% 1096
2023
Q3 		$312K Sell
32,400
-188,878
-85% -$1.85M ﹤0.01% 1317
2023
Q2 		$2.35M Buy
+221,278
New +$2.38M 0.02% 700
2023
Q1 		– Sell
-24,700
Closed -$306K – 2348
2022
Q4 		$306K Sell
24,700
-121,863
-83% -$1.38M ﹤0.01% 1780
2022
Q3 		$1.52M Buy
+146,563
New +$1.66M 0.01% 1012
2022
Q1 		– Sell
-40,200
Closed -$469K – 2743
2021
Q4 		$469K Buy
40,200
+3,200
+9% +$39.3K ﹤0.01% 1297
2021
Q3 		$484K Sell
37,000
-10,118
-21% -$131K 0.01% 1290
2021
Q2 		$607K Buy
+47,118
New +$539K 0.01% 1101
2020
Q2 		– Sell
-21,677
Closed -$219K – 1382
2020
Q1 		$219K Buy
21,677
+7,054
+48% +$82.9K 0.01% 880
2019
Q4 		$195K Buy
14,623
+3,723
+34% +$41K ﹤0.01% 1172
2019
Q3 		$94K Buy
+10,900
New +$106K ﹤0.01% 951
2018
Q2 		– Sell
-90,977
Closed -$1.18M – 852
2018
Q1 		$1.18M Buy
+90,977
New +$1.13M 0.09% 289
2017
Q3 		– Sell
-90,041
Closed -$1.42M – 683
2017
Q2 		$1.42M Sell
90,041
-239,159
-73% -$3.48M 0.15% 205
2017
Q1 		$4.7M Buy
329,200
+113,228
+52% +$1.55M 0.47% 50
2016
Q4 		$2.77M Buy
+215,972
New +$2.73M 0.36% 75

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Steve Schonfeld's IRWD Position: Q2 2026 in Review

Steve Schonfeld reduced its Ironwood Pharmaceuticals (IRWD) stake by 51% in Q2 2026, selling an estimated $115K and leaving 28,428 shares worth $120K. The position accounts for ﹤0.01% of the portfolio, ranked #2279.

Steve Schonfeld first reported a position in IRWD in Q4 2016 and has held it in 22 quarters since. The position peaked at $11.4M in Q1 2024. 211 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Steve Schonfeld held 28,428 shares of Ironwood Pharmaceuticals worth $120K as of Q2 2026.
  • Steve Schonfeld sold 29,949 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $115K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Steve Schonfeld's portfolio in Q2 2026, its #2279 holding.
  • Steve Schonfeld first reported a position in Ironwood Pharmaceuticals in Q4 2016 and has held it in 22 quarters since.
  • Steve Schonfeld's Ironwood Pharmaceuticals position peaked at $11.4M in Q1 2024.
  • 211 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.